Infumorph 200 Injection, Solution
Product Images NDC 0641-6039

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Infumorph 200 (NDC 0641-6039). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fiigure From Plr (Infumorph 1)

Fiigure From Plr (Infumorph 1)
Not available.*
FDA Label Image

Structure (Infumorph 2)

FDA Label Image

Infumorph 200 (preservative-free Morphine Sulfate Sterile Solution) Cii 200 mg/20 mL (10 mg/ml) 20 mL Ampul Ampul Label (Infumorph 3)

Infumorph 200 (preservative-free Morphine Sulfate Sterile Solution) Cii 200 mg/20 mL (10 mg/ml) 20 mL Ampul Ampul Label (Infumorph 3)
Infumorph 200 is a preservative-free morphine sulfate sterile solution that comes in a 20 mL single-dose ampoule. It should not be used for IV, IM, or subcutaneous injection and is only for neuraxial administration in continuous microinfusion devices. The solution needs to be filtered before use, and any unused portion must be discarded. If there is a precipitate in the solution, it should not be used, and the solution should be colorless or pale yellow. The solution should be stored at a controlled room temperature of between 68 and 77 degrees Fahrenheit and should be protected from light. The text also provides an NDC number and a lot number for identification purposes.*
FDA Label Image

462-214-02 (Infumorph 4)

462-214-02 (Infumorph 4)
Description: Infumorph 200 is an injectable drug used for pain management. It comes in a single-dose ampule with a concentration of 200mg per 20mL (10mg/mL). The solution should not be heated or frozen, and it should be discarded if the color changes or if there are any undissolved particles after shaking. The ampule should be opened by ignoring the color. Infumorph 200 should be infused continuously using microinfusion devices. The output contains some typos and is difficult to read accurately in some places.*
FDA Label Image

Infumorph 500 (preservative-free Morphine Sulfate Solution) Cii 500 mg/20 mL (25 mg/ml) 20 mL Ampul Ampul Label (Infumorph 5)

Infumorph 500 (preservative-free Morphine Sulfate Solution) Cii 500 mg/20 mL (25 mg/ml) 20 mL Ampul Ampul Label (Infumorph 5)
Infumorph 500 is a prescription medication that contains Morphine Sulfate Sterte Solution. This solution is preservative-free and comes in a 20mL single-dose ampoule. It is not intended for IV, IM, or subcutaneous injection. Infumorph 500 is administered through continuous microinfusion devices and filtered before use. The unused portion must be discarded. The solution should be colorless or pale yellow, and if it contains a precipitate that does not disappear upon shaking, it should not be used. Infumorph 500 should be stored at room temperature, protected from light, and not frozen.*
FDA Label Image

462-216-02 (Infumorph 6)

462-216-02 (Infumorph 6)
This is a prescription for the medication Infumorph 500, which is a sterile solution of preservative-free Morphine Sulfate. It comes in a 20 ml vial with a concentration of 500 mg of Morphine per 20 ml, or 25 mg/mL. It is intended for administration with continuous micro-infusion devices for neuraxial use. It also contains instructions on how to open the ampule for usage.*
FDA Label Image

Layout 1 (Infumorph 7)

Layout 1 (Infumorph 7)
This text represents product identification and expiration information. The GTIN is a barcode number used to identify the product, the SN is a serial number assigned to a specific item, and the EXP denotes the expiration date in the format of month abbreviation and year. The LOT is a unique identifier for a specific production batch.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.